简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Lingyi iTech
Six New Stocks Show Divergent Grey Market Performance; Ketuo Biotech Leads with 156% Surge While MERDEKA GOLD Tumbles 43%
Tags:
Keytop
CFMEE
Zhongke WengeAI
SG Micro
Lingyi iTech
MERDEKAGOLD-DRS
IPO
grey market trading
2026-06-25
Lingyi iTECH (01688.HK) IPO Priced at HK$10.18/Share, Debut Expected June 26
Tags:
Lingyi iTech
01688.HK
IPO
2026-06-24
Lingyi iTech (01688.HK) Launches IPO: Max Offer Price at HK$10.18, Entry Fee Around HK$6,787 per Lot
Tags:
Lingyi iTech
01688.HK
IPO
2026-06-17
Lingyi iTECH Passes HKEX Hearing, Ranked World’s No.1 in High-Precision Components for AI End Devices
Tags:
Lingyi iTech
002600.SZ
A+H
IPO
通过聆讯
2026-06-08
Lingyi iTech (Guangdong) Company Re-files for Hong Kong IPO, Ranked First in Global AI Terminal Device High-Precision Functional Components Market
Tags:
Lingyi iTech
IPO
refile listing application
2026-05-21
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App